Open access · CC BY-NC 4.0
Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention
Cardiovascular Prevention and Pharmacotherapy · 2019
DOI: 10.36011/cpp.2019.1.e1 ↗At a glance
Journal article in Cardiovascular Prevention and Pharmacotherapy, 2019. Written by Jang-Whan Bae. Cited 1 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Δεν υπάρχει διαθέσιμη περίληψη.
Cite
APA
Bae, J. (2019). Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. https://doi.org/10.36011/cpp.2019.1.e1
Vancouver
Bae J. Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. 2019. doi:10.36011/cpp.2019.1.e1
BibTeX
@article{Bae2019,
author = {Bae, Jang-Whan},
title = {Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention},
journal = {Cardiovascular Prevention and Pharmacotherapy},
year = {2019},
doi = {10.36011/cpp.2019.1.e1}
}
EUVIMED